Document is current
Any future updates will be listed below
-
Authors
Farrant, John P.
Black, Nicholas
Yamagata, Kentaro
Soltani, Fardad
Orsborne, Christopher
Yan, Chi Kit
Clark, David
Pleva, Luke
Garratt, Clifford
Schmitt, Matthias
Clarke, Bernard
Naish, Josephine
Reid, Anna
Miller, Christopher A.
-
Funding
Funding for this research was provided by:
British Heart Foundation (FS/CRTF24/24601)
National Institute for Health and Care Research (NIHR301338)
University of Manchester British Heart Foundation Research Excellence Award (RE/24/130017)
- License Information
-
More Information
Article History
Received: 5 December 2024
Accepted: 24 February 2025
First Online: 27 March 2025
Declarations
:
: CAM has participated on advisory boards/consulted for AstraZeneca, Boehringer Ingelheim and Lilly Alliance, Novartis and PureTech Health, serves as an advisor for HAYA Therapeutics, has received speaker fees from AstraZeneca, Boehringer Ingelheim and Novo Nordisk, conference attendance support from AstraZeneca, and research support from Amicus Therapeutics, AstraZeneca, Guerbet Laboratories Limited, Roche and Univar Solutions B.V. The authors declare no competing interests.
